» Articles » PMID: 5101783

Etiology of Hyperparathyroidism and Bone Disease During Chronic Hemodialysis. I. Association of Bone Disease with Potentially Etiologic Factors

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1971 Mar 1
PMID 5101783
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The present study was prompted by the observation that, in patients with chronic renal failure being followed at this center, renal osteodystrophy developed almost exclusively in those who were treated by chronic hemodialysis at home rather than in our center. A systematic comparison was made between the 10 patients with roentgenographic evidence of the bone disease and 18 patients without demonstrable bone disease. The two groups were similar in age, sex, nature of renal disease, and duration of dialysis. The mean duration of kidney disease was almost 2 yr longer in the patients without bone disease than in those with bone disease. Other significant differences related to where the hemodialysis was performed and to the calcium concentration in the dialysate (6.0-7.4 mg/100 ml in the hospital and 4.9-5.6 mg/100 ml at home). If the unknown factors related to where the dialysis was performed were of no consequence, the major factor contributing to the production of bone disease observed in these patients was the use of a dialysate with a calcium concentration less than 5.7 mg/100 ml.

Citing Articles

Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. II. Factors affecting serum immunoreactive parathyroid hormone.

Fournier A, Arnaud C, Johnson W, Taylor W, GOLDSMITH R J Clin Invest. 1971; 50(3):599-605.

PMID: 5545122 PMC: 291968. DOI: 10.1172/JCI106530.


Study on the influence of dialysis with varying bath calcium concentrations on the different plasma calcium fractions.

Verberckmoes R Klin Wochenschr. 1972; 50(9):480-2.

PMID: 5043471 DOI: 10.1007/BF01487606.


Bone disease in hemodialysis patients with particular reference to the effect of fluoride.

Cordy P, Gagnon R, Taves D, Kaye M Can Med Assoc J. 1974; 110(12):1349-53.

PMID: 4834525 PMC: 1947652.


Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility.

GOLDSMITH R, Furszyfer J, Johnson W, Fournier A, Sizemore G, Arnaud C J Clin Invest. 1973; 52(1):173-80.

PMID: 4734166 PMC: 302239. DOI: 10.1172/JCI107161.


Calcium uptake and phosphate removal during hemodialysis with variing dialysate calcium.

Skrabal F, Dittrich P, GABL F Klin Wochenschr. 1974; 52(6):266-71.

PMID: 4412279 DOI: 10.1007/BF01468456.


References
1.
PENDRAS J, ERICKSON R . Hemodialysis: a successful therapy for chronic uremia. Ann Intern Med. 1966; 64(2):293-311. DOI: 10.7326/0003-4819-64-2-293. View

2.
BERNSTEIN D, Sadowsky N, HEGSTED D, GURI C, STARE F . Prevalence of osteoporosis in high- and low-fluoride areas in North Dakota. JAMA. 1966; 198(5):499-504. View

3.
Ogden D, Holmes J . Changes in total and ultrafilterable plasma calcium and magnesium during hemodialysis. Trans Am Soc Artif Intern Organs. 1966; 12:200-4. View

4.
Freeman R, LAWTON R, Chamberlain M . Hard-water syndrome. N Engl J Med. 1967; 276(20):1113-8. DOI: 10.1056/NEJM196705182762003. View

5.
Taves D . Normal human serum fluoride concentrations. Nature. 1966; 211(5045):192-3. DOI: 10.1038/211192b0. View